METTL14-mediated m6A modification of TNFAIP3 involved in inflammation in patients with active rheumatoid arthritis.

Jifeng TangZiqing YuJinfang XiaRenquan JiangShuhui ChenDetai YeHuiming ShengJin-Piao Lin

Published in: Arthritis & rheumatology (Hoboken, N.J.) (2023)

Our study highlights the critical roles of m6A on regulation of inflammation in RA progression. Treatment strategies targeting m6A modification may represent a new option for management of RA. This article is protected by copyright. All rights reserved.

Keyphrases

rheumatoid arthritis
disease activity
oxidative stress
ankylosing spondylitis
systemic lupus erythematosus
interstitial lung disease
drug delivery